← Back to Search

Other

Breath Test Development for Respiratory Diseases (EBC Trial)

N/A
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the exhaled breath collection procedure, not to exceed 30 minutes
Awards & highlights

EBC Trial Summary

This trial is designed to help create new breath tests for various medical conditions.

Who is the study for?
This trial is for people aged 4-110 with acute or chronic respiratory disorders, metabolic or systemic conditions with widespread inflammation, and healthy individuals without lung disease. Participants must be willing and able to cooperate with breath collection procedures.Check my eligibility
What is being tested?
The study focuses on optimizing the way we collect and analyze exhaled biomarkers from participants. It's an exploratory study aiming to create pilot data that will help form more specific research questions in future studies.See study design
What are the potential side effects?
Since this trial involves only breath collection, there are no direct side effects associated with typical drug interventions. However, discomfort or inconvenience during the breath collection process may occur.

EBC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the exhaled breath collection procedure, not to exceed 30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the exhaled breath collection procedure, not to exceed 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Breath amount, pH, components

EBC Trial Design

1Treatment groups
Experimental Treatment
Group I: Single Visit breath collectionExperimental Treatment1 Intervention
Following informed consent, exhaled breath will be passively collected from subjects during quiet oral breathing through a simple mouthpiece or mask. Exhaled breath will be diverted into a collection device, which may include a bag, tube, or other device with minimal resistance. The collection process, including completing forms, will not exceed 30 minutes. At no time will the patients be breathing anything other than ambient air with or without oxygen enrichment as clinically indicated. Inhaled air will not be manipulated.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,161 Total Patients Enrolled

Media Library

Breath Collection (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05322785 — N/A
Respiratory Diseases Research Study Groups: Single Visit breath collection
Respiratory Diseases Clinical Trial 2023: Breath Collection Highlights & Side Effects. Trial Name: NCT05322785 — N/A
Breath Collection (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05322785 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age criterion of this clinical experiment permit participation by participants under 80 years old?

"This medical trial seeks to enroll patients between 4 and 110 years old. There are 65 pediatric studies available for those under the age of 18, while 440 adults aged over 65 may participate in the extended study."

Answered by AI

What criteria must be met in order to sign up for this clinical research program?

"This study seeks 1000 participants aged 4 to 110 with healthy subjects (hs) that may also have acute or chronic respiratory disorders, systemic issues involving diffuse inflammation, or no pulmonary disease."

Answered by AI

Are there still openings available in this clinical experiment?

"As per the clinicaltrials.gov information, this medical trial has closed recruitment as of April 7th 2022 after initially being posted on February 2nd 2020. However, there are an abundance of alternative studies actively recruiting patients at present with 920 trials available in total."

Answered by AI
Recent research and studies
Paediatric Respiratory ReviewsJournal
Exhaled Breath Testing – A Tool for the Clinician and Researcher
Davis, Michael D., Stephen J. Fowler, and Alison J. Montpetit. 2019. “Exhaled Breath Testing – A Tool for the Clinician and Researcher”. Paediatric Respiratory Reviews. Elsevier BV. doi:10.1016/j.prrv.2018.05.002.
Immunology and Allergy Clinics of North AmericaJournal
Exhaled Breath Condensate
Davis, Michael D., and Alison J. Montpetit. 2018. “Exhaled Breath Condensate”. Immunology and Allergy Clinics of North America. Elsevier BV. doi:10.1016/j.iac.2018.06.002.
European Respiratory JournalJournal
Exhaled Breath Condensate Ph Is a Robust and Reproducible Assay of Airway Acidity
Vaughan, J., L. Ngamtrakulpanit, T.N. Pajewski, R. Turner, T-A. Nguyen, A. Smith, P. Urban, S. Hom, B. Gaston, and J. Hunt. 2003. “Exhaled Breath Condensate Ph Is a Robust and Reproducible Assay of Airway Acidity”. European Respiratory Journal. European Respiratory Society (ERS). doi:10.1183/09031936.03.00038803.
clinicaltrials.govStudy
Optimization of Exhaled Biomarker Collection and Analysis
Michael D. Davis 2020. "Optimization of Exhaled Biomarker Collection and Analysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05322785.
~580 spots leftby Jan 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top